Stock UniverseDerived research view · source repositories remain read-only

Artiva Biotherapeutics, Inc. (ARTV)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
21.26
Global Rank
3198
Market Cap
142.85M
Latest Close
6.85
RS Composite
30.12% · G#291

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-44.71%
3M
19.34%
6M
91.34%
1Y
247.72%
3Y
-42.92%
5Y
-42.92%
10Y
-42.92%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 356.92K · 30-day average: 560.32K · Max drawdown over stored range: -90.71%

Research Snapshot

Relative Strength vs SPX

RS Composite30.12%
20D RS-45.92%
60D RS-12.90%
120D RS111.16%
Global RS Rank291 · 91.33% percentile
Watch+Speculative RS Rank170 · 91.89% percentile
Group ScopeWatch+Speculative
Primary RS Rank45 · 90.17% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank414 / 701
Primary Percentile41.08
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for ARTV.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue02.0024.93133.4920.251
Revenue Growth (YoY)2600%2600%146.304%579.213%-99.251%
Gross Profit02.0024.93133.4920.251
Operating Income-18.271-53.272-59.829-30.671-67.282
Free Cash Flow-13.825-17.028-57.128-50.688-55.674-79.338
Free Cash Flow Per Share-21.893-24.829-74.508-63.143-4.945-3.245696898841301
EPS (Diluted) GAAP-28.489672-104.72834-76.672666-35.77715-5.806365
EPS Growth
EPS Non-GAAP
Gross Margin2600%100%100%100%100%
Operating Margin2600%-2660.939%-1213.324%-91.577%-26805.578%
Profit Margin2600%-3587.662%-1192.213%-85.752%-26045.02%
Free Cash Flow Margin2600%-850.549%-1158.548%-151.344%-22180.876%
Shares Outstanding (Diluted)0.63150.68580.76670.802711.258924.4441
Shares Change (YoY)3.59%8.603%11.799%4.696%1302.54%117.11%

SEC Quarterly Fundamentals

No processed quarterly rows for ARTV.